Anthony Vecchione
AMD is making a $20 million equity investment to bolster Absci's drug discovery efforts and expand AMDs accelerators and ROCm software.
The expansion includes prescribing capabilities and entry into the direct-to-consumer market.
The app will allow patients to register digitally in less than 60 seconds and schedule appointments.
The company will use the funds to accelerate development of its screening device.
Guardian's members with disabilities will receive an Uber voucher for medical appointments.
The alliance will allow Amazon customers to benefit from Teladoc's cardiometabolic programs.
Augmedix and Vizient will provide Augmedix Go, Augmedix Assist and Augmedix Live to providers and healthcare systems.
The aim is to apply AI to deliver more personalized care and derive insights on population health and disease progression.
Century Health’s AI platform will create structured datasets based on multiple sclerosis patient data collected from Nira Medical’s network of clinics.
The company will use the funds to increase research and development efforts to make robotics surgery more accessible.